Novel approach to estimate tuberculosis transmission in primary care clinics in sub-Saharan Africa: protocol of a prospective study.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
26 08 2020
Historique:
entrez: 28 8 2020
pubmed: 28 8 2020
medline: 15 5 2021
Statut: epublish

Résumé

Tuberculosis (TB) transmission is difficult to measure, and its drivers are not well understood. The effectiveness of infection control measures at healthcare clinics and the most appropriate intervention strategies to interrupt transmission are unclear. We propose a novel approach using clinical, environmental and position-tracking data to study the risk of TB transmission at primary care clinics in TB and HIV high burden settings in sub-Saharan Africa. We describe a novel and rapid study design to assess risk factors for airborne TB transmission at primary care clinics in high-burden settings. The study protocol combines a range of different measurements. We will collect anonymous data on the number of patients, waiting times and patient movements using video sensors. Also, we will collect acoustic sound recordings to determine the frequency and intensity of coughing. Environmental data will include indoor carbon dioxide levels (CO The study was approved by the University of Cape Town (HREC/REF no. 228/2019), the City of Cape Town (ID-8139) and the Ethics Committee of the Canton Bern (2019-02131), Switzerland. The results will be disseminated in international peer-reviewed journals.

Identifiants

pubmed: 32847906
pii: bmjopen-2019-036214
doi: 10.1136/bmjopen-2019-036214
pmc: PMC7451471
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e036214

Subventions

Organisme : NIAID NIH HHS
ID : U01 AI069924
Pays : United States

Informations de copyright

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Eur Respir J. 2008 May;31(5):1013-8
pubmed: 18184683
Lancet Infect Dis. 2013 Feb;13(2):137-46
pubmed: 23158499
BMJ Open. 2020 May 15;10(5):e035246
pubmed: 32414825
PLoS One. 2011;6(10):e25098
pubmed: 22016763
PLoS One. 2014 Sep 02;9(9):e106622
pubmed: 25181526
J Pathog. 2013;2013:493960
pubmed: 23365758
J Med Internet Res. 2017 Dec 19;19(12):e347
pubmed: 29258059
Indoor Air. 2003 Sep;13(3):237-45
pubmed: 12950586
Anal Chem. 2017 Apr 18;89(8):4461-4467
pubmed: 28350455
Lancet Respir Med. 2019 Jun;7(6):465
pubmed: 31122731
Emerg Infect Dis. 1997 Jul-Sep;3(3):335-42
pubmed: 9284378
PLoS Med. 2007 Oct 16;4(10):e297
pubmed: 17941715
BMC Infect Dis. 2014 Apr 23;14:221
pubmed: 24758715
J Acquir Immune Defic Syndr. 2011 Mar 1;56(3):263-9
pubmed: 21317585
Bull World Health Organ. 2012 Oct 1;90(10):739-747A
pubmed: 23109741
J Infect Dis. 2014 Aug 15;210(4):597-603
pubmed: 24610874
PLoS One. 2014 May 07;9(5):e96334
pubmed: 24804707
J Theor Biol. 2015 May 7;372:100-6
pubmed: 25702940
Int J Tuberc Lung Dis. 2012;16(3):297-305
pubmed: 22136695
Am J Respir Crit Care Med. 2007 Jan 1;175(1):87-93
pubmed: 16973982
Gates Open Res. 2017 Nov 7;1:11
pubmed: 29355225
PLoS One. 2015 Aug 19;10(8):e0135179
pubmed: 26288079
Int J Tuberc Lung Dis. 2019 Apr 1;23(4):465-473
pubmed: 31064626
J Biomed Inform. 2019 Jul;95:103208
pubmed: 31078660
BMC Public Health. 2003 Jan 13;3:5
pubmed: 12525263
Am J Epidemiol. 1995 Jul 1;142(1):3-14
pubmed: 7785671
Physiol Meas. 2018 Apr 26;39(4):045005
pubmed: 29543189
J Infect Dis. 2015 Jan 1;211(1):53-61
pubmed: 25053739

Auteurs

Kathrin Zürcher (K)

Institute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland.

Carl Morrow (C)

Desmond Tutu HIV Centre, Institute of Infectious Disease and Molecular Medicine (IDM), University of Cape Town, Cape Town, South Africa.
Institute of Infectious Disease and Molecular Medicine and the Department of Medicine, University of Cape Town, Rondebosch, Western Cape, South Africa.

Julien Riou (J)

Institute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland.

Marie Ballif (M)

Institute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland.

Anastasia Sideris Koch (AS)

Institute of Infectious Disease and Molecular Medicine and the Department of Medicine, University of Cape Town, Rondebosch, Western Cape, South Africa.
Molecular Mycobacteriology Research Unit, University of Cape Town, Rondebosch, Western Cape, South Africa.

Simon Bertschinger (S)

Institute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland.
Medical Informatics, Berne University of Applied Sciences, Bern, Switzerland.

Xin Liu (X)

Paul G. Allen School of Computer Science & Engineering, University of Washington, Seattle, Washington, USA.

Manuja Sharma (M)

Paul G. Allen School of Computer Science & Engineering, University of Washington, Seattle, Washington, USA.

Keren Middelkoop (K)

Desmond Tutu HIV Centre, Institute of Infectious Disease and Molecular Medicine (IDM), University of Cape Town, Cape Town, South Africa.
Institute of Infectious Disease and Molecular Medicine and the Department of Medicine, University of Cape Town, Rondebosch, Western Cape, South Africa.

Digby Warner (D)

Institute of Infectious Disease and Molecular Medicine and the Department of Medicine, University of Cape Town, Rondebosch, Western Cape, South Africa.
Molecular Mycobacteriology Research Unit, University of Cape Town, Rondebosch, Western Cape, South Africa.

Robin Wood (R)

Desmond Tutu HIV Centre, Institute of Infectious Disease and Molecular Medicine (IDM), University of Cape Town, Cape Town, South Africa.
Institute of Infectious Disease and Molecular Medicine and the Department of Medicine, University of Cape Town, Rondebosch, Western Cape, South Africa.

Matthias Egger (M)

Institute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland.
Centre for Infectious Disease Epidemiology & Research, School of Public Health & Family Medicine, University of Cape Town, Rondebosch, Western Cape, South Africa.
Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.

Lukas Fenner (L)

Institute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland lukas.fenner@ispm.unibe.ch.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH